Delivery Order SPE2DP24D0005-SPE2DP24F3249
Award Date
3/14/24
Potential Completion Date
9/20/24
Potential Value
$1.6M
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
This federal contract award for $2,408,448.00 was issued by the Medical Supply Chain division of the U.S. Department of Defense to the pharmaceutical company Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The contract is a firm fixed price delivery order with no set-aside designation, and performance will occur at Glaxosmithkline's facilities in North Carolina. This award is part of a larger indefinite delivery vehicle (IDV) contract held by Glaxosmithkline to provide a range...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S....
This federal contract award was issued by the Office of the Assistant Secretary for Administration, a civilian agency, to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of vaccines. The contract, which is not set-aside, has a ceiling value of $133,372.10 and is a firm fixed price delivery order under the GSA Pharmaceuticals and Drugs Schedule. The contract supports the government's vaccine stockpiling initiatives and provides influenza and hepatitis vaccines, COVID-19...
This federal contract award, SPE2DP15D0006|0008, was issued by the U.S. Defense Logistics Agency (DLA) to the prime contractor GlaxoSmithKline, LLC for the delivery of influenza virus vaccines. The $100,660.00 firm fixed price contract has a completion date of November 30, 2015 and does not have a set-aside designation. GlaxoSmithKline is a global pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to U.S. government agencies through federal contracts...
This federal contract award to Glaxosmithkline, LLC ("Glaxosmithkline") is for the delivery of vaccines for the U.S. government. The $194,863.47 firm fixed price contract was awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, and is associated with the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) indefinite delivery vehicle. The contract has no set-aside designation and the place of performance is Glaxosmithkline's...
This federal contract was awarded by the U.S. Department of Health and Human Services (HHS) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to government agencies. The $121,881.06 delivery order contract is for Glaxo vaccines, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The contract has a firm fixed price pricing type and was not set aside for any small business...
This federal contract award is for vaccines and pharmaceutical products provided to the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration by GlaxoSmithKline, LLC. The contract has a potential value of $115,680.30, is a firm fixed price delivery order, and is not set aside for any specific business type. The contract was awarded on September 12, 2017, with a completion date of September 22, 2017. GlaxoSmithKline, a large pharmaceutical company, has...
This federal contract award to Glaxosmithkline, LLC, valued at $205,578.36, is for the delivery of vaccines to the U.S. government. The contract was issued by the Office of the Assistant Secretary for Administration, a civilian agency, and is not designated as a set-aside. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a firm fixed-price delivery order. Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral...